Preferences help
enabled [disable] Abstract
Number of results
2015 | 86 | 10 | 473-478
Article title

Cide-A Gene Expression in Patients with Obesity Qualified for Endovascular Treatment of Abdominal Aorta Aneurysm

Title variants
Languages of publication
CIDE-A gene and the genes of LRP group play a key role in the regulation of the body weight and lipid metabolism in mammals. CIDE-A is defined as a potential human obesity gene and the LRP1 gene is associated with the development of abdominal aortic aneurysm (AAA).The aim of the study was to define the role of CIDE-A gene in patients with dyslipidemia and asymptomatic AAA.Material and methods. The study group consisted of 38 subjects, including 27 men and 11 women qualified for endovascular aneurysm repair (EVAR). The subjects with abdominal aortic aneurysm were enrolled in the study group, depending on the body mass index (BMI); in obese patients (BMI > 30). The control group (n = 16) included subjects without lipid disorders. One-step isolation of RNA from lymphocytes and adipose tissue cells was performed using the modified TRI method by Chomc-zynski and Sacchi, and then the gene expression was tested by real-time PCR.Results. The highest mean relative of the gene expression for CIDE-A was reported in subjects with the normal body weight. The lowest mean relative of the gene expression for CIDE-A was observed in the group of obese patients with aortic aneurysm and lipid disorders. A high negative correlation (r = -0.7101) in the gene expression for CIDE-A was observed in the group of obese patients with aortic aneurysm, depending on the BMI.Conclusions. Due to the important role of the CIDE-A gene and Cide-A protein in the development of metabolic syndrome, obesity and the accompanying vascular lesions such as abdominal aortic an-eurysm, seen in this context, the tested gene and protein Cide-A represent a potential therapeutic target in these diseases.
Physical description
3 - 2 - 2015
6 - 8 - 2014
  • 1. Klop B, Elte J, Cabezas MC: Dyslipidemia in obesity: mechanisms and potentials targets. Nutrients 2013; 5(4): 1218-40.[WoS][Crossref]
  • 2. Miller Jr FJ, sharp WJ, Fang X et al.: Oxidative stress in human aortic aneurysm: a potential mediator of aneurismal remodeling. Arterioscler Thromb Vasc Biol 2002; 22: 560-65.[Crossref]
  • 3. Feldo M, Kocki J, Łukasik S i wsp.: Ekspresja genu CIDE-A u chorych z otyłością brzuszną i hy-perlipoproteinemią LDL zakwalifikowanych chirurgicznej rewaskularyzacji w przewlekłym niedokrwieniu kończyn dolnych. (CIDE-A gene expression in patients with abdominal obesity and LDL hyperlipoproteinemia qualified for surgical revascularisation in chronic limb ischemia). Pol Przegl Chir 2013; 85 (11): 1166-73.
  • 4. Eagleton MJ: Inflammation in abdominal aortic aneurysm: cellular infiltrate and cytokine profiles. Vascular 2012; 20: 278-83.[PubMed][Crossref]
  • 5. Musunuru K: Atherogegic dyslipidemia: cardiovascular risk and dietary intervention. Lipids 2010; 45: 907-14.[WoS][PubMed][Crossref]
  • 6. Puri V, Ranjit S, Konda S et al.: Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci 2008; 105: 7833-38.[Crossref]
  • 7. WildB, Stather PW, Syvius N et al.: Low density lipoprotein receptor related protein 1 and abdominal aortic aneurysms. Eur J Vasc Endovascular Surg 2012; 44: 127-32.[Crossref]
  • 8. Hofmann FS, Zhou L, Pereztilve D, Greer T et al.: Adipocyte LDL receptor related protein 1 expression modulate posprandial modulate lipid transport and glucose homeostasis in mice. J Clin Invest 2007; 117: 3217-82.[WoS]
  • 9. Gaultier, A, Arandielovic S, Niessen S et al.: Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the anti inflammatory activity of this receptor. Blood 2008; 111: 5316-25.[Crossref][WoS]
  • 10. Gonzalez P, Alvarez R, Reguero JR et al.: Variations in the lipoprotein receptor related protein alpha2-macroglobulin and lipoprotein receptor associated protein genes in relation to plasma lipid levels and risk of recent myocardial infarction. Coron Artery Dis 2002; 13: 251-54.
  • 11. Su AI, Wiltshire T, Batalov S et al.: A gene atlas of the mouse and the human proteins transcrip-toms. Proc Natl Acad Sci USA 2004; 101: 6062-67.[Crossref]
  • 12. Paravastu SC, Jayarajasingam R, Cottam R et al.: Cocharane Database Syst Rev. 2014; 23: 1: CD004178.doi:10.1002/14651858.[Crossref]
  • 13. Chomczyński P, Sacchi N: Single-step metod of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-59.[Crossref]
  • 14. Li D, Da L, Tang H et al.: CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding. nucleic Acids res 2008; 36: 330-41.
  • 15. SiemińskaL: Tkanka tłuszczowa. Patofizjologia, rozmieszczenie, różnice płciowe oraz znaczenie w procesach zapalnych i nowotworowych. Pol J Endocrinol 2007; 58: 330-42.
  • 16. Guilherme A, Virbasius JV, Puri V, Czech MP: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes nature R«v Mol Cell Biol 2008; 9: 367-77.[WoS]
  • 17. Nordstrom EA, Ryden M, Backlund EC et al.: A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes 2005; 54:1726-34.[Crossref]
  • 18. Ryden M, Dicker A, van Harmelen V et al.: Mapping of early signaling events in tumor necrosis factor-alpha-mediated lipolysis in human fat cells. J Biol Chem 2002; 277: 1085-91.
  • 19. Gong, J, Sun z,. Li P: CIDE proteins and metabolic disorders. Curr Opin Lipidol 2009; 20: 121-26.[PubMed][Crossref]
  • 20. Murphy S, Martin S, Parton RG: Lipid drople-t-organelle interactions; sharing the fats. Biochim Biophys Acta 2009; 1791: 441-47.
  • 21. Puri V, Czech MP: Lipid droplets: FSP27 knockout enhances their sizzle. J Clin Invest 2008; 118: 2693-96.[WoS]
  • 22. Puri V, ranjit S, Konda S et al.: Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA 2008; 105: 7833-38.[Crossref]
  • 23. Puri V, Virbasius JV, Guilherme A et al.: RNAi screens reveal novel metabolic regulators: RIP 140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27. Acta Physiol (Oxf) 2008; 192: 103-15.
  • 24. Viguerie N, Vidal H, Arner P et al.: Nutrient-Gene Interactions in Human Obesity - Implications for Dietary Guideline (NUGENOB) project: Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetol 2005;48: 123-31.[Crossref]
  • 25. Xu L, Zhou L, Li P: Cide proteins and lipid metabolism. Thrombosis and Vascular Biology 2012; 32: 1094-98.[WoS][Crossref]
  • 26. Cnop M, Landchild MJ, Vidal J et al.: The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002; 51: 1005-15.[Crossref]
  • 27. Gummesson A, Jernas M, Svensson PA et al.: Relations of adipose tissue CIDE-A gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies. J Clin Endocrinol Metab 2007; 92: 4759-65.[WoS][Crossref]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.